Getting the skinny on the latest diet pills


Wall Street is betting that three new experimental diet drugs could be huge commercial hits in a super-sizing America, but how comfortable would doctors be with prescribing the pills?. Clinical studies have shown all three -- Vivus Inc.'s (VVUS 5.61, +0.21, +3.89%) Qnexa, Orexigen Therapeutics' (OREX 4.73, +0.18, +3.96%) Contrave and Arena Pharmaceuticals' (ARNA 6.75, +0.16, +2.35%) lorcaserin-- can be effective in helping obese patients lose at least 5% of their body weight. In some cases, patients were even able to shed over 10%, especially when used in conjunction with a diet and exercise regimen. While 5% may sound unimpressive to your average weight watcher, doctors say that even that relatively small drop can yield substantial health benefits. "In diabetes, losing 5% to 10% of body weight can have a big effect. It can have a significant impact on glucose control," said Dr. Kenneth Snow, senior staff physician at the Joslin Diabetes Center in Boston. And as Americans' waist-lines expand, so does the demand for better weight-loss treatments. See CDC obesity statistics.

Read »

learn spanish app ipad apps for kids swift programming tutorial

Getting the skinny on the latest diet pills